The evidence for PERK signaling activation in PD was provided by a number of preclinical studies [13,14], and increased p-PERK and p-eIF2α levels were detected in brain specimens from PD patients [14,15]. This evidence concerns the gene EIF2AK3 and Parkinson disease.